WO1998036730A3 - Compositions de traitement de l'acne rosacee - Google Patents
Compositions de traitement de l'acne rosacee Download PDFInfo
- Publication number
- WO1998036730A3 WO1998036730A3 PCT/EP1998/000991 EP9800991W WO9836730A3 WO 1998036730 A3 WO1998036730 A3 WO 1998036730A3 EP 9800991 W EP9800991 W EP 9800991W WO 9836730 A3 WO9836730 A3 WO 9836730A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- acne rosacea
- treating acne
- rosacea
- prevention
- Prior art date
Links
- 201000004700 rosacea Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53626998A JP2001512471A (ja) | 1997-02-21 | 1998-02-20 | しゅさの処置のための調製物 |
EP98913571A EP0969790A2 (fr) | 1997-02-21 | 1998-02-20 | Compositions de traitement de l'acne rosacee |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19706581 | 1997-02-21 | ||
DE19711565A DE19711565A1 (de) | 1997-02-21 | 1997-03-20 | Zubereitungen für die Behandlung von Rosacea |
DE19706581.3 | 1997-03-20 | ||
DE19711565.9 | 1997-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998036730A2 WO1998036730A2 (fr) | 1998-08-27 |
WO1998036730A3 true WO1998036730A3 (fr) | 1998-10-22 |
Family
ID=26034114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/000991 WO1998036730A2 (fr) | 1997-02-21 | 1998-02-20 | Compositions de traitement de l'acne rosacee |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0969790A2 (fr) |
JP (1) | JP2001512471A (fr) |
WO (1) | WO1998036730A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19918750A1 (de) * | 1999-04-24 | 2000-10-26 | Beiersdorf Ag | Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion |
FR2794974B1 (fr) * | 1999-06-16 | 2001-08-17 | Exsymol Sa | Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique |
FR2808189B1 (fr) * | 2000-04-28 | 2004-03-05 | Oreal | Lipochroman-6 comme inhibiteur de no-synthase et utilisations |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
JP4814567B2 (ja) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | 健康機能向上剤 |
JP4814501B2 (ja) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | 抗酸化機能向上剤 |
JP4814568B2 (ja) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | 免疫機能向上剤 |
AU2005278649B8 (en) | 2004-09-02 | 2010-07-22 | Cosmo Ala Co., Ltd. | Constitutional function-improving agents |
EP2653160B1 (fr) * | 2006-10-12 | 2017-09-27 | Topaz Pharmaceuticals Inc. | Formulations topiques d'ivermectine et procédés d'élimination et prophylaxie de souches des morpions |
EP2116237A1 (fr) | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions pour traiter la rosacée comprenants du chitosane et un acide dicarboxylique |
JP2011063541A (ja) * | 2009-09-17 | 2011-03-31 | Tokyo Institute Of Technology | L−アルギニン結合因子の精製方法及びl−アルギニン様化合物のスクリーニング方法 |
EP2329849B1 (fr) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire |
US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
CN106038476B (zh) | 2010-03-26 | 2020-04-17 | 盖尔德马研究及发展公司 | 安全和有效治疗红斑的改进的方法和组合物 |
AU2011231544B2 (en) | 2010-03-26 | 2015-01-15 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of telangiectasia |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
EP2629757A2 (fr) | 2010-10-21 | 2013-08-28 | Galderma S.A. | Compositions de gel de brimonidine et leurs procédés d'utilisation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631776A1 (fr) * | 1993-07-02 | 1995-01-04 | Roussel Uclaf | Utilisation de dérivés de la bêta-naphtoquinone pour l'accélération de la prolifération des cellules endothéliales et de l'inhibition des no synthases |
WO1995024884A1 (fr) * | 1994-03-16 | 1995-09-21 | Handelman, Joseph, H. | Inhibition de la croissance pileuse |
WO1996026711A1 (fr) * | 1995-02-27 | 1996-09-06 | L'oreal | Inhibiteurs de no-synthase |
WO1997015280A1 (fr) * | 1995-10-26 | 1997-05-01 | L'oreal | Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles |
FR2744915A1 (fr) * | 1996-02-16 | 1997-08-22 | Oreal | Composition cosmetique a base de cellules indifferenciees de ginkgo biloba |
-
1998
- 1998-02-20 JP JP53626998A patent/JP2001512471A/ja active Pending
- 1998-02-20 WO PCT/EP1998/000991 patent/WO1998036730A2/fr not_active Application Discontinuation
- 1998-02-20 EP EP98913571A patent/EP0969790A2/fr not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631776A1 (fr) * | 1993-07-02 | 1995-01-04 | Roussel Uclaf | Utilisation de dérivés de la bêta-naphtoquinone pour l'accélération de la prolifération des cellules endothéliales et de l'inhibition des no synthases |
WO1995024884A1 (fr) * | 1994-03-16 | 1995-09-21 | Handelman, Joseph, H. | Inhibition de la croissance pileuse |
WO1996026711A1 (fr) * | 1995-02-27 | 1996-09-06 | L'oreal | Inhibiteurs de no-synthase |
WO1997015280A1 (fr) * | 1995-10-26 | 1997-05-01 | L'oreal | Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles |
FR2744915A1 (fr) * | 1996-02-16 | 1997-08-22 | Oreal | Composition cosmetique a base de cellules indifferenciees de ginkgo biloba |
Non-Patent Citations (3)
Title |
---|
A.A.QURESHI ET AL.: "From Bedside to the Bench and Back", ARCH. DERMATOL., vol. 132, no. 8, August 1996 (1996-08-01), pages 889 - 903, XP002075669 * |
G.SAUERMANN ET AL.: "Influence of NO-Synthase Antagonists in Rosacea Patients", J.INVEST DERMATOL., vol. 108, no. 4, April 1997 (1997-04-01), pages 657, XP002075670 * |
S.M.BIRNBAUM ET AL.: "Preparation of the Optical Isomers of Arginine, Histidine and S-Benzylcysteine by Asymmetric Enzymatic Hydrolysis of their Acetyl Derivatives", ARCH.BIOCHEM., vol. 39, 1952, pages 108 - 118, XP002075668 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998036730A2 (fr) | 1998-08-27 |
JP2001512471A (ja) | 2001-08-21 |
EP0969790A2 (fr) | 2000-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998036730A3 (fr) | Compositions de traitement de l'acne rosacee | |
CA2267186A1 (fr) | Application d'inhibiteurs de la cyclogenase-2 au traitement et a la prevention du processus neoplasique | |
ZA981132B (en) | Methods, compositions and articles for reducing or preventing the effects of inflammation. | |
WO2002072031A3 (fr) | Composes de tetracycline substitue utilises en tant qu'antifongiques synergiques | |
WO2002047706A3 (fr) | Inhibition sélective de la cox-2 au moyen d'extraits végétaux | |
WO1999004752A3 (fr) | Procede pour le traitement de la pigmentation de la peau | |
WO1996021655A3 (fr) | Inhibiteurs de la calpaine et/ou de la cathepsine b derives d'oxazolidine substituee | |
WO2000037107A3 (fr) | Procede d'utilisation d'un inhibiteur de cyclooxygenase-2 et d'un inhibiteur de metalloproteinase matricielle en tant que therapie combinee dans le traitement de la neoplasie | |
WO2001015678A3 (fr) | Utilisation topique d'agonistes des kappa opioides afin de traiter les douleurs oculaires | |
WO2001051043A3 (fr) | Compositions et methodes de traitement de maladies neoplasiques au moyen de combinaisons de limonoides, de flavonoides et de tocotrienols | |
WO1999015167A3 (fr) | Utilisation de limonoides et de flavonoides d'agrumes et de tocotrienols pour le traitement du cancer | |
WO2003053383A3 (fr) | Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques | |
CA2257010A1 (fr) | Methodes et compositions pour le traitement et la prevention des tumeurs, des troubles relies a des tumeurs et de la cachexie | |
WO1994004541A3 (fr) | Inhibiteurs de proteine kinase et composes apparentes combines avec du taxol | |
ZA973487B (en) | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment. | |
WO2001017543A3 (fr) | Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer | |
WO2000009101A3 (fr) | Utilisation de composes oestrogenes en tant qu'agents antifongiques | |
WO1997004788A3 (fr) | Utilisation de glycosides de calendula dans le traitement du psoriasis | |
WO2000021513A3 (fr) | Procedes pour traiter la sclerose en plaques | |
AU8853998A (en) | Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis | |
AU2002232400A1 (en) | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis | |
CA2275167A1 (fr) | Utilisation locale d'agonistes opioides kappa dans le traitement de la douleur oculaire | |
WO1998022101A3 (fr) | Procede d'utilisation d'inhibiteurs de cyclo-oxygenase-2 comme agents anti-angiogeniques | |
EP1171145A4 (fr) | Utilisation de la catechine pour la prevention ou le traitement de la restenose coronarienne | |
MXPA00007394A (es) | Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998913571 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 536269 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09367748 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998913571 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998913571 Country of ref document: EP |